Advertisement
Australia markets closed
  • ALL ORDS

    8,083.10
    -35.20 (-0.43%)
     
  • AUD/USD

    0.6642
    +0.0020 (+0.31%)
     
  • ASX 200

    7,811.80
    -36.30 (-0.46%)
     
  • OIL

    78.17
    +0.60 (+0.77%)
     
  • GOLD

    2,368.40
    -24.50 (-1.02%)
     
  • Bitcoin AUD

    105,323.84
    +77.17 (+0.07%)
     
  • CMC Crypto 200

    1,508.85
    +6.19 (+0.41%)
     
Powerball's $150 million jackpot :

Winning numbers revealed

3 Mid-Cap Stocks That Will Help You Build Long-Term Wealth

fizkes / Getty Images/iStockphoto
fizkes / Getty Images/iStockphoto

Mid-cap stocks, from companies with a market capitalization between $2 billion and $10 billion, according to FINRA, are easy to overlook. Yet, many experts say they’re worth considering because they have room for growth, especially compared to large-cap stocks (market cap between $10 billion and $200 billion) and small-cap stocks (market cap between $250 million and $2 billion).

Be Aware: 401(k) Growth Potential: Ways to Double Your Savings in 10 Years

Check Out: One Smart Way To Grow Your Retirement Savings in 2024

These stocks are also worth investing in for diversification, as they have the advantages of both small- and large-cap stocks, according to Zacks. The highest-ranked have the potential to enhance their profitability, and they may become large caps over time, Zacks added.

ADVERTISEMENT

Here are some worth considering:

Crescent Point Energy

Crescent Point Energy is an oil and gas exploration, development and production company operating in the U.S. and Canada.

  • Market cap as of May 3: $5.25 billion

  • Stock price: $8.50

  • Year-to-date: 22.83%

  • Past year: 23.9%

  • Past month: 0.12%

TipRanks noted that the stock has an average price target of $10.76, which implies a 24.39% upside potential.

Smartsheet

Smartsheet is a software-as-service company whose platform helps distributed teams plan, manage, automate and report on projects.

  • Market cap as of May 3: $5.30 billion

  • Stock price: $38.58

  • Year-to-date: -17.23%

  • Past year: -1.58%

  • Past month: 1.13%

As TipRanks noted, the stock’s price forecast stood at $47.93, which implies a 24.24% upside.

Exelixis

Exelixis is a biotech company involved in the discovery, development and commercialization of cancer treatments.

  • Market cap as of May 3: $6.38 billion

  • Stock price: $21.90

  • Year-to-date: -8.48%

  • Past year: 14%

  • Past month: -7.56%

TipRanks reported that the stock has a 21.14% upside.

More From GOBankingRates

Stock data was collected from Google Finance and Yahoo Finance on May 3, 2024.

This article originally appeared on GOBankingRates.com: 3 Mid-Cap Stocks That Will Help You Build Long-Term Wealth